Geoffrey Kim
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Immunology
- Cancer Research
- Co-authors
- Richard PazdurShenghui TangV. Ellen MaherHarpreet SinghLijun ZhangRajeshwari SridharaJulia A. BeaverKirsten B. Goldberg
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)Health Systems, Economic Evaluations, Quality of Life (5 papers)Economic and Financial Impacts of Cancer (4 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Geoffrey Kim
29 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 83
- Oncology 621
- Pulmonary and Respiratory Medicine 354
- Molecular Biology 205
- Immunology 156
- Cancer Research 142
Countries citing papers authored by Geoffrey Kim
This map shows the geographic impact of Geoffrey Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Kim more than expected).
Fields of papers citing papers by Geoffrey Kim
This network shows the impact of papers produced by Geoffrey Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Kim. The network helps show where Geoffrey Kim may publish in the future.
Co-authorship network of co-authors of Geoffrey Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Kim. A scholar is included among the top collaborators of Geoffrey Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Kim. Geoffrey Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | 13 | |
| 5 | 29 | |
| 6 | 6 | |
| 7 | 115 | |
| 8 | 22 | |
| 9 | 4 | |
| 10 | 109 | |
| 11 | 26 | |
| 12 | 3 | |
| 13 | 40 | |
| 14 | 5 | |
| 15 | 33 | |
| 16 | 57 | |
| 17 | 13 | |
| 18 | 35 | |
| 19 | 52 | |
| 20 | 20 |
About Geoffrey Kim
Geoffrey Kim is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Economic and Financial Impacts of Cancer (4 papers). The work is most often cited by research in Oncology (621 citations), Geriatrics and Gerontology (43 citations) and Pulmonary and Respiratory Medicine (354 citations). Geoffrey Kim has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Richard Pazdur, Shenghui Tang, V. Ellen Maher, Harpreet Singh, Lijun Zhang, Rajeshwari Sridhara, Julia A. Beaver, Kirsten B. Goldberg, Daniel L. Suzman and Sean Khozin. Their work appears in journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.